查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美快速检测试剂盒市场预测至 2030 年 - 区域分析 - 按类型、产品、技术、应用和最终用户
市场调查报告书
商品编码
1562199

北美快速检测试剂盒市场预测至 2030 年 - 区域分析 - 按类型、产品、技术、应用和最终用户

North America Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type, Product, Technology, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 157 Pages | 订单完成后即时交付

价格

2022年北美快速检测试剂盒市值为68.694亿美元，预计到2030年将达到104.6282亿美元；预计2022年至2030年复合年增长率为5.4%。

遗传性疾病和传染病患者病率的上升推动了北美快速检测试剂盒市场

MJH Life Sciences（美国）2022 年的报告估计，全球每年有 30 万名新生儿出生时患有镰状细胞疾病。根据疾病预防控制中心 (CDC) 的数据，每 500 名非裔美国人中就有 1 人患有镰状细胞疾病。世界卫生组织 (WHO) 最新发布的《2022 年世界疟疾报告 (WMR)》指出，2021 年全球报告了近 2.47 亿例新发疟疾病例，而 2020 年记录的病例为 2.45 亿例。造成的死亡人数为61.9万人。

Sickle SCAN 是一种快速检测镰状细胞性贫血的方法，具有高灵敏度和特异性。快速诊断测试 (RDT) 透过检测人体血液中是否存在疟疾寄生虫来帮助诊断疟疾。在获得高品质显微镜服务的机会有限的情况下，放射诊断技术被用作临床或基于显微镜的诊断的替代方法。 COVID-19 大流行对快速检测试剂盒市场产生了重大影响。几乎所有诊断测试都使用即时 PCR 来测试表现出 SARS-CoV-2 感染症状的人。快速检测试剂盒几乎无所不在、强大且可靠。大多数分子生物学实验室都使用快速测试技术，包括扩增特定 DNA 片段以进行基因分型、克隆和单核苷酸变异分析。因此，遗传性疾病和传染病发病率的增加推动了快速检测试剂盒市场的成长。

北美快速检测试剂盒市场概况

CRISPR 和 PCR 等基因合成和编辑工具在研究和治疗中的快速采用需要有助于快速定量、改变和观察的检测方法。美国正在向公共和私人组织寻求大量资金，预计将在先进研究方法上进行大量投资，并预计在快速检测试剂盒市场中处于领先地位。在 SARS-CoV-2 Delta 流行期间和 Omicron 流行期间，家庭测试的使用量迅速增加。据 CDC 称，2023 年 4 月，美国各地运送了超过 7,000 万份检测试剂盒。

北美快速检测试剂盒市场收入及 2030 年预测（百万美元）

北美快速检测试剂盒市场细分

北美快速检测试剂盒市场根据类型、产品、技术、应用、最终用户和国家进行细分。根据类型，北美快速检测试剂盒市场分为快速抗原检测、快速抗体检测等。 2022 年，快速抗原检测领域占据最大的市场。

从产品来看，北美快速检测试剂盒市场分为非处方快速检测试剂盒和专业快速检测试剂盒。非处方快速检测试剂盒细分市场在 2022 年占据更大的市场。

依技术划分，北美快速检测试剂盒市场分为侧流检测、固相检测、凝集检测、免疫斑点检测和基于细胞成分的检测。 2022 年，侧流分析领域占据最大的市场份额。

根据应用，北美快速检测试剂盒市场分为血糖检测、传染病检测、怀孕及生育、心臟代谢检测等。 2022年，血糖检测领域占据最大的市场份额。

就最终用户而言，北美快速检测试剂盒市场分为医院和诊所、家庭护理、诊断中心等。 2022 年，医院和诊所领域占据最大的市场。

根据国家/地区，北美快速检测试剂盒市场分为美国、加拿大和墨西哥。 2022年，美国在北美快速检测试剂盒市场份额中占据主导地位。

F. Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、广州万孚生物科技有限公司、Denka Co Ltd、 Abbott Laboratories 、Trinity Biotech Plc、SD Biosensor Inc、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA 和 Beckman Coulter Inc 是北美快速检测试剂盒市场的一些领先参与者。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美快速测试套件市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病和传染病的盛行率不断上升
    • 製造商的策略倡议
  • 市场限制
    • 与结果准确性相关的不确定性
  • 市场机会
    • 对 PCR 技术的偏好不断增加
  • 未来趋势
    • 快速抗原检测的创新
  • 影响分析

第 5 章：快速测试套件市场 - 北美市场分析

  • 概述
  • 快速测试套件市场收入，2020 - 2030

第 6 章：北美快速检测试剂盒市场分析 - 按类型

  • 概述
  • 快速抗原检测
  • 快速抗体检测
  • 其他的

第 7 章：北美快速检测试剂盒市场分析 - 按产品

  • 概述
  • 非处方快速检测试剂盒
  • 专业快速检测试剂盒

第 8 章：北美快速检测试剂盒市场分析 - 按技术

  • 概述
  • 侧流层析
  • 固相
  • 凝集
  • 免疫斑点测定
  • 基于蜂窝组件

第 9 章：北美快速检测试剂盒市场分析 - 按应用

  • 概述
  • 血糖测试
  • 传染病检测
  • 心臟代谢测试
  • 怀孕和生育
  • 其他的

第 10 章：北美快速测试套件市场分析 - 按最终用户

  • 概述
  • 医院和诊所
  • 诊断中心
  • 居家护理
  • 其他的

第 11 章：北美快速检测试剂盒市场 - 国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第 12 章：产业格局

  • 概述
  • 快速检测试剂盒市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 13 章：公司简介

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Denka Co Ltd
  • Abbott Laboratories
  • Trinity Biotech Plc
  • SD Biosensor Inc
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • DiaSorin SpA
  • Beckman Coulter Inc

第 14 章：附录

Product Code: BMIRE00030521

The North America rapid test kit market was valued at US$ 6,869.40 million in 2022 and is expected to reach US$ 10,462.82 million by 2030; it is estimated to record a CAGR of 5.4% from 2022 to 2030.

Rising Prevalence of Genetic and Infectious Diseases Fuels North America Rapid Test Kit Market

A 2022 report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year. According to the CDC, 1 in 500 African Americans is affected by sickle cell disease. The latest World Malaria Report (WMR) 2022 from the World Health Organization (WHO) states that nearly 247 million new malaria cases were reported in the world in 2021, in comparison to 245 million cases that were logged in 2020. According to the same source, the number of deaths caused due to malaria was 619,000 in 2021.

Sickle SCAN is a rapid test for the identification of sickle cell anemia with high sensitivity and specificity. Rapid diagnostic tests (RDTs) help diagnose malaria by detecting the presence of malarial parasites in human blood. Where access to high-quality microscopy services is limited, radiological diagnosis techniques are used as an alternative for clinical or microscope-based diagnosis. The COVID-19 pandemic had a significant impact on the rapid test kits market. Nearly all diagnostic tests used real-time PCR for testing people who showed symptoms of SARS-CoV-2 infection. Rapid test kits are nearly ubiquitous, robust, and reliable. Rapid testing techniques that involve the amplification of specific stretches of DNA for genotyping, cloning, and single nucleotide variation analysis are used in most molecular biology labs. Thus, the increasing incidence of genetic and infectious diseases propels the growth of the rapid test kits market.

North America Rapid Test Kit Market Overview

The rapid adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that are helpful in terms of rapid quantification, alterations, and observation. The US, seeking significant funding from public and private organizations, is expected to invest significantly in advanced research methodologies and is expected to be in the leading position in the rapid test kits market. There was a rapid increase in at-home test use occurred between the SARS-CoV-2 Delta- and Omicron-predominant periods of the pandemic. According to the CDC, in April 2023, more than 70 million test kits were shipped across the US.

North America Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

North America Rapid Test Kit Market Segmentation

The North America rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the North America rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the North America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the North America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the North America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the North America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the North America rapid test kit market is segmented into the US, Canada, and Mexico. The US dominated the North America rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the North America rapid test kit market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Rapid Test Kits Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.1.2 Strategic Initiatives by Manufacturers
  • 4.2 Market Restraints
    • 4.2.1 Uncertainties Related to Accuracy of Results
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Preference for PCR Techniques
  • 4.4 Future Trends
    • 4.4.1 Innovations in Rapid Antigen Tests
  • 4.5 Impact Analysis

5. Rapid Test Kits Market - North America Market Analysis

  • 5.1 Overview
  • 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. North America Rapid Test Kits Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Rapid Antigen Testing
    • 6.2.1 Overview
    • 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Rapid Antibody Testing
    • 6.3.1 Overview
    • 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Rapid Test Kits Market Analysis - by Product

  • 7.1 Overview
  • 7.2 Over-the-Counter Rapid Testing Kit
    • 7.2.1 Overview
    • 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Professional Rapid Testing Kit
    • 7.3.1 Overview
    • 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Rapid Test Kits Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Lateral Flow Assay
    • 8.2.1 Overview
    • 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Solid Phase
    • 8.3.1 Overview
    • 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Agglutination
    • 8.4.1 Overview
    • 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Immunospot Assay
    • 8.5.1 Overview
    • 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cellular-Component Based
    • 8.6.1 Overview
    • 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Rapid Test Kits Market Analysis - by Application

  • 9.1 Overview
  • 9.2 Blood Glucose Testing
    • 9.2.1 Overview
    • 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Infectious Disease Testing
    • 9.3.1 Overview
    • 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cardiometabolic Testing
    • 9.4.1 Overview
    • 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pregnancy and Fertility
    • 9.5.1 Overview
    • 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Rapid Test Kits Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospital and Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Home-Care
    • 10.4.1 Overview
    • 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Rapid Test Kits Market - Country Analysis

  • 11.1 North America: Rapid Test Kits Market
    • 11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 United States
        • 11.1.1.1.1 Overview
      • 11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.3 Canada
        • 11.1.1.3.1 Overview
      • 11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Overview
      • 11.1.1.6 Mexico
        • 11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Rapid Test Kit Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Becton Dickinson and Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ARKRAY Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Fujirebio Europe NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 bioMerieux SA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Cepheid
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Meril Life Sciences Pvt Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 QIAGEN NV
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 OraSure Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Guangzhou Wondfo Biotech Co Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Denka Co Ltd
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Abbott Laboratories
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Trinity Biotech Plc
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 SD Biosensor Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Bio-Rad Laboratories Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Hologic Inc
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 DiaSorin SpA
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 Beckman Coulter Inc
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. Rapid Test Kits Market Segmentation
  • Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 4. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 5. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 6. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 7. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 8. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 10. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 11. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 12. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 13. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 14. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 16. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 17. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 18. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 20. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
  • Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market

List Of Figures

  • Figure 1. Rapid Test Kits Market Segmentation, By Country
  • Figure 2. Rapid Test Kits Market: Key Industry Dynamics
  • Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
  • Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
  • Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
  • Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
  • Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
  • Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America: Rapid Test Kits Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 31. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Growth Strategies in the Rapid Test Kit Market